307 related articles for article (PubMed ID: 21227726)
1. Retrospective review of Japanese sudden unexpected death in infancy: the importance of metabolic autopsy and expanded newborn screening.
Yamamoto T; Tanaka H; Kobayashi H; Okamura K; Tanaka T; Emoto Y; Sugimoto K; Nakatome M; Sakai N; Kuroki H; Yamaguchi S; Matoba R
Mol Genet Metab; 2011 Apr; 102(4):399-406. PubMed ID: 21227726
[TBL] [Abstract][Full Text] [Related]
2. Metabolic autopsy with postmortem cultured fibroblasts in sudden unexpected death in infancy: diagnosis of mitochondrial respiratory chain disorders.
Yamamoto T; Emoto Y; Murayama K; Tanaka H; Kuriu Y; Ohtake A; Matoba R
Mol Genet Metab; 2012 Aug; 106(4):474-7. PubMed ID: 22658691
[TBL] [Abstract][Full Text] [Related]
3. Arrhythmias and conduction defects as presenting symptoms of fatty acid oxidation disorders in children.
Bonnet D; Martin D; Pascale De Lonlay ; Villain E; Jouvet P; Rabier D; Brivet M; Saudubray JM
Circulation; 1999 Nov; 100(22):2248-53. PubMed ID: 10577999
[TBL] [Abstract][Full Text] [Related]
4. Follow-up of fatty acid β-oxidation disorders in expanded newborn screening era.
Janeiro P; Jotta R; Ramos R; Florindo C; Ventura FV; Vilarinho L; Tavares de Almeida I; Gaspar A
Eur J Pediatr; 2019 Mar; 178(3):387-394. PubMed ID: 30617651
[TBL] [Abstract][Full Text] [Related]
5. Postmortem screening for fatty acid oxidation disorders by analysis of Guthrie cards with tandem mass spectrometry in sudden unexpected death in infancy.
Wilcox RL; Nelson CC; Stenzel P; Steiner RD
J Pediatr; 2002 Dec; 141(6):833-6. PubMed ID: 12461502
[TBL] [Abstract][Full Text] [Related]
6. Tandem mass spectrometry findings at autopsy for detection of metabolic disease in infant deaths: postmortem changes and confounding factors.
Pryce JW; Weber MA; Heales S; Malone M; Sebire NJ
J Clin Pathol; 2011 Nov; 64(11):1005-9. PubMed ID: 21896576
[TBL] [Abstract][Full Text] [Related]
7. Post-mortem analysis for two prevalent beta-oxidation mutations in sudden infant death.
Yang Z; Lantz PE; Ibdah JA
Pediatr Int; 2007 Dec; 49(6):883-7. PubMed ID: 18045290
[TBL] [Abstract][Full Text] [Related]
8. Retrospective biochemical screening of fatty acid oxidation disorders in postmortem livers of 418 cases of sudden death in the first year of life.
Boles RG; Buck EA; Blitzer MG; Platt MS; Cowan TM; Martin SK; Yoon H; Madsen JA; Reyes-Mugica M; Rinaldo P
J Pediatr; 1998 Jun; 132(6):924-33. PubMed ID: 9627580
[TBL] [Abstract][Full Text] [Related]
9. Carnitine palmitoyltransferase 2 gene polymorphism is a genetic risk factor for sudden unexpected death in infancy.
Yamamoto T; Tanaka H; Emoto Y; Umehara T; Fukahori Y; Kuriu Y; Matoba R; Ikematsu K
Brain Dev; 2014 Jun; 36(6):479-83. PubMed ID: 23969168
[TBL] [Abstract][Full Text] [Related]
10. A neonatal death due to medium-chain acyl-CoA dehydrogenase deficiency: utilization of the neonatal metabolic screen in a functional approach to sudden unexplained infant death.
Manoukian AA; Ha CE; Seaver LH; Bhagavan NV
Am J Forensic Med Pathol; 2009 Sep; 30(3):284-6. PubMed ID: 19696588
[TBL] [Abstract][Full Text] [Related]
11. Neonatal carnitine palmitoyltransferase II deficiency associated with Dandy-Walker syndrome and sudden death.
Yahyaoui R; Espinosa MG; Gómez C; Dayaldasani A; Rueda I; Roldán A; Ugarte M; Lastra G; Pérez V
Mol Genet Metab; 2011 Nov; 104(3):414-6. PubMed ID: 21641254
[TBL] [Abstract][Full Text] [Related]
12. Molecular diagnosis for a fatal case of very long-chain acyl-CoA dehydrogenase deficiency in Hong Kong Chinese with a novel mutation: a preventable death by newborn screening.
Siu WK; Mak CM; Siu SL; Siu TS; Pang CY; Lam CW; Kwong NS; Chan AY
Diagn Mol Pathol; 2012 Sep; 21(3):184-7. PubMed ID: 22847164
[TBL] [Abstract][Full Text] [Related]
13. Normal acylcarnitine levels during confirmation of abnormal newborn screening in long-chain fatty acid oxidation defects.
Browning MF; Larson C; Strauss A; Marsden DL
J Inherit Metab Dis; 2005; 28(4):545-50. PubMed ID: 15902557
[TBL] [Abstract][Full Text] [Related]
14. Diagnosis of mitochondrial trifunctional protein deficiency in a blood spot from the newborn screening card by tandem mass spectrometry and DNA analysis.
Matern D; Strauss AW; Hillman SL; Mayatepek E; Millington DS; Trefz FK
Pediatr Res; 1999 Jul; 46(1):45-9. PubMed ID: 10400133
[TBL] [Abstract][Full Text] [Related]
15. Autopsy case of the neonatal form of carnitine palmitoyltransferase-II deficiency triggered by a novel disease-causing mutation del1737C.
Semba S; Yasujima H; Takano T; Yokozaki H
Pathol Int; 2008 Jul; 58(7):436-41. PubMed ID: 18577113
[TBL] [Abstract][Full Text] [Related]
16. Electrospray tandem mass spectrometry for analysis of acylcarnitines in dried postmortem blood specimens collected at autopsy from infants with unexplained cause of death.
Chace DH; DiPerna JC; Mitchell BL; Sgroi B; Hofman LF; Naylor EW
Clin Chem; 2001; 47(7):1166-82. PubMed ID: 11427446
[TBL] [Abstract][Full Text] [Related]
17. Post-mortem MRI reveals CPT2 deficiency after sudden infant death.
Bouchireb K; Teychene AM; Rigal O; de Lonlay P; Valayannopoulos V; Gaudelus J; Sellier N; Bonnefont JP; Brivet M; de Pontual L
Eur J Pediatr; 2010 Dec; 169(12):1561-3. PubMed ID: 20661589
[TBL] [Abstract][Full Text] [Related]
18. Differences between acylcarnitine profiles in plasma and bloodspots.
de Sain-van der Velden MG; Diekman EF; Jans JJ; van der Ham M; Prinsen BH; Visser G; Verhoeven-Duif NM
Mol Genet Metab; 2013; 110(1-2):116-21. PubMed ID: 23639448
[TBL] [Abstract][Full Text] [Related]
19. Differentiation of long-chain fatty acid oxidation disorders using alternative precursors and acylcarnitine profiling in fibroblasts.
Roe DS; Yang BZ; Vianey-Saban C; Struys E; Sweetman L; Roe CR
Mol Genet Metab; 2006 Jan; 87(1):40-7. PubMed ID: 16297647
[TBL] [Abstract][Full Text] [Related]
20. [Acute fatty liver in pregnancy: revealing fetal fatty acid oxidation disorders].
Lamireau D; Feghali H; Redonnet-Vernhet I; Mesli S; Carles D; Brissaud O
Arch Pediatr; 2012 Mar; 19(3):277-81. PubMed ID: 22325456
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
